C4 Therapeutics Inc (CCCC)
Healthcare
Biotechnology
3.50 $
+0.6%
vs. previous close
Closing price · As of: 3. Aug 2026
C4 Therapeutics Inc (CCCC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -30 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19 | -31 | -24 | -18 | -5.0 | -24 | -18 | -33 | -12 | -31 | -22 | -30 | -95 | |
| 0.5 | 0.4 | 1.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | 0.4 | 0.4 | 1.9 | |
| 6.4 | 8.2 | 6.4 | 6.2 | 6.4 | 8.8 | 8.2 | 5.5 | 5.0 | 4.6 | 4.0 | 2.7 | 16 | |
| 6.9 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 9.4 | -13 | 3.4 | 3.4 | 5.9 | -9.0 | 7.4 | -14 | 7.2 | -16 | -6.7 | -8.3 | -24 | |
| 0.4 | 0.6 | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.2 | 0.4 | 0.0 | 0.1 | 0.7 | |
| 15 | 58 | 32 | -53 | -12 | 0.2 | 14 | 29 | 39 | 4.1 | -81 | 16 | -22 | |
| 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | -0.2 | -0.2 | |
| -0.8 | – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| -0.7 | -11 | 58 | 35 | 0.1 | 11 | 0.1 | 0.0 | 0.0 | 7.8 | 119 | 0.5 | 127 | |
| -4.6 | 16 | 66 | -37 | -17 | -13 | -4.2 | -4.2 | 27 | -19 | 16 | -13 | 10.0 | |
| -19 | -31 | -24 | -18 | -5.2 | -24 | -18 | -33 | -12 | -32 | -22 | -30 | -96 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.